Copea Pharma Limited
08592240
Healthy
No risk factors detected.
Details
Compliance
Accounts
Confirmation statement
Industry
Officers
director · Since 01/07/2013
COMPANY DIRECTOR
BRITISH · ENGLAND · Age 52
Also on 9 other boards
Persons with Significant Control
Mr Mark John Dignum
British · England · Age 52
25 Compass West, Spindus Road, Liverpool, L24 1YA
Notified 30/06/2016
Former PSCs
Miss Pamela Ann Turner
Ceased 06/03/2020
CompanyRankvs 63+ SIC 21100 peers83
Show leaderboard
How is this score calculated?
Net worth compared to all companies in the same SIC code with published accounts. Top quartile earns the full 25 points.
Workforce size relative to sector peers from the most recent accounts. A larger team generally signals commercial scale.
Current assets ÷ current liabilities. A ratio above 2× earns full marks; between 1–2× scores partially; below 0.5× scores minimal points.
One point per year of operation since incorporation, capped at 15. Older companies have a proven track record.
Full 15 points when both annual accounts and confirmation statement are filed on time. Points are deducted for each overdue filing.
Maximum score is 100. Deductions apply for insolvency history, outstanding charges, going concern doubt, or disqualified officers.
Key FinancialsYear ending 31/03/2025
Net Worth
£1.1M
Balance sheet strength
Cash
£342k
Cash in the bank
Net Current Assets
£527k
Working capital
Current Assets
£999k
Current Liabilities
£472k
Fixed Assets
£556k
Debtors
£657k
Balance Sheet
EstimatesDerived
| Year | Current Ratio | Implied Profit |
|---|---|---|
| 2025 | 2.12 | +£684k |
| 2024 | 2.84 | +£126k |
| 2023 | 3.67 | -£31k |
| 2022 | 5.67 | -£16k |
| 2021 | 2.75 | — |
| 2019 | 1.80 | — |
| 2018 | 1.52 | — |
Derived from filed accounts. Not audited figures.